Dear all,
I'm sure you're aware of the GIRFT work on Pathology workstreams. Following on from some recent discussions about artefactual hyperkalaemia, we have been thinking here about how we start to describe the effect on patients. The GIRFT report is going to look at zero length of stay admissions to ED that have hyperkalaemia in the admission code.
In order to triangulate this with actual lab data, we have looked at what happens to potassium results taken in primary care and then within 48h in ED.
We would like to examine the effect in other areas if possible. Would people be willing to share anonymised data to expand the pool of information?
If others are keen we could add other hospital data to this methodology and see if anything interesting comes out. All we would need is a spreadsheet of April 2018/March 2019 data with :
1. Date of specimen
2. Site of requestor (GP or ED)
3. Anonymised patient identifier (all we do is rank the results by NHS number and then convert to simple ordinal numbers – we can write an SOP for this if it’s not quite obvious)
4. Potassium result.
We could then disseminate the information once reviewed.
regards
Mary
---
Mary Stapleton FRCPath
Biochemistry Department,
Northern Devon Healthcare Trust,
Raleigh Park,
Barnstaple,
EX31 4JB
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual who posts and they are solely responsible for all message content. The ACB does not monitor posts.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|